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Exposure of human keratinocytes to ultraviolet A (UVA) radiation at physiological doses leads to a biphasic
activation of transcription factor activator protein-2 (AP-2) and subsequently to a biphasic increase in gene ex-
pression of, e.g. intercellular adhesion molecule-1 (ICAM-1). Both kinetics follow a pattern with a ﬁrst peak between
0.5 and 2 h and a second, more sustained activation between 16 and 48 h. We have previously reported on a non-
enzymatic triggering of the ceramide signaling cascade as the initiating step in UVA radiation-induced signaling. In
this study, we report that this early (0.5–1 h) peak in ceramide content is followed by a second peak that (i) was
associated with an increased expression and activity of serine palmitoyltransferase, the key enzyme of ceramide
synthesis, (ii) could be prevented by inhibitors of this enzyme, and (iii) was of functional relevance because its
inhibition abrogated the second, but not the ﬁrst peak in UVA radiation-induced ICAM-1 gene expression. We
hypothesize that this second peak most likely resulted from a ceramide-mediated autocrine loop, for (i) inhibition of
the ﬁrst ceramide peak resulted in inhibition of the second peak and (ii) cell-permeable ceramides-induced serine
palmitoyltransferase expression, activity, and subsequently ceramide content.
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Solar ultraviolet A (UVA; 320–400 nm) radiation is known to
induce gene expression in human cells. The photobiological
and molecular mechanisms are under current investigation
as solar UVA radiation-induced gene expression is causally
involved in photoaging, the pathogenesis of frequent pho-
todermatoses such as polymorphous light eruption, and, in
particular, in photocarcinogenesis. In human epidermal ker-
atinocytes, which represent the primary target cells for sun-
light, UVA radiation-induced expression of genes including
intercellular adhesion molecule-1 (ICAM-1) and vascular
endothelial growth factor was previously shown to be me-
diated through activation of the transcription factor activator
protein-2 (AP-2) (Grether-Beck et al, 1996; Morita et al,
1997; Gille et al, 2000). This UVA response followed a
biphasic pattern: a first early maximum of AP-2 activation
between 30 min and 2 h after exposure was followed by a
second, more sustained activation that could be observed 8
h after irradiation and that was still detectable 48 h post-
UVA. Similarly, UVA radiation-induced gene transcription
showed a biphasic regulation with a first early maximum
within 30 min to 4 h and a second, longer lasting increase in
mRNA levels from 16 h up to 48 h after irradiation. This
biphasic pattern is characteristic for UVA radiation, whereas
UVB (290–320 nm) radiation induces a monophasic, late
ceramide response1 and gene expression (Krutmann et al,
1992).
The molecular basis for the biphasic nature of the UVA
response has thus far remained unclear. We have previously
shown that UVA signaling is initiated through the formation
of second messenger ceramide in human epidermal kera-
tinocytes. In general, ceramide generation may occur by
hydrolysis from sphingomyelin through neutral and acid
sphingomyelinases, degradation of glycosphingolipids, de
novo synthesis by ceramide synthase, or by non-enzymatic
mechanisms, which are still poorly understood. In this re-
gard, UVA radiation-induced ceramide content was found
to be mediated by a non-enzymatic mechanism that result-
ed from the UVA radiation-induced generation of singlet
oxygen and that caused a rapid, but transient increase in
ceramide levels between 0.5 and 2 h after irradiation
(Grether-Beck et al, 2000). These observations, however,
do not explain the second phase of the UVA response,
which—because of its long-lasting nature—may be of par-
ticular biological significance.
In this study, we have therefore assessed whether cer-
amide signaling is of relevance for the later part of the UVA
response as well. We have observed that the first, non-
enzymatic ceramide peak is followed by a second, much
Abbreviations: AP-2, activator protein-2; ICAM, intercellular adhe-
sion molecule-1; UV, ultraviolet
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more sustained ceramide production, which is because of
de novo synthesis. We also present evidence that the non-
enzymatic peak initiates this second peak through activa-
tion of serine palmitoyltransferase and thereby mediates the
sustained increase in AP-2 activation and gene expression
that can be observed up to 48 h post-irradiation.
Results
Time course of UVA radiation-induced ICAM-1 mRNA
expression and ceramide content UVA radiation induces
gene transcription in human keratinocytes in a biphasic
manner (Grether-Beck et al, 1996; Gille et al, 2000). Ac-
cordingly, ICAM-1 mRNA steady-state levels were upregu-
lated between 2 and 4 h after exposure to 30 J per cm2 of
UVA radiation, a dose that was previously shown to effec-
tively induce gene expression but not to reduce viability in
this cell type (Grether-Beck et al, 1996; 2000; Warskulat
et al, 2004). This first maximum was followed by a second
increase after 24 h (Fig 1A). We now report that biphasic
ICAM-1 mRNA expression is associated with a biphasic in-
crease in ceramide content in UVA-irradiated cells. Expo-
sure of keratinocytes to an identical dose of UVA radiation
resulted in an approximately 5-fold increase in the level of
ceramide between 30 min and 2 h after irradiation, thus
confirming previous results (Grether-Beck et al, 2000). This
early peak in ceramide content was followed by a second,
more sustained increase that could be detected 16 h after
exposure and that was still 2.5-fold higher than the back-
ground level 48 h after irradiation (Fig 1B). A UVA-induced
2.5-fold increase in other lipid components of the cytoplas-
mic membrane i.e. cholesterol and phosphatidylcholine has
been observed during the first 4 h post-treatment (unpub-
lished observation). This is in contrast to observations in
mice where 2–3-fold increases of cholesterol and phos-
pholipids had been detected as early as 72 h post-appli-
cation of 7.5 MED UVB (Holleran et al, 1997).
UVA radiation-induced ceramide content is mediated by
non-enzymatic and enzymatic mechanisms Ceramide
can be generated by sphingomyelinase, which hydrolyzes
sphingomyelin to produce phosphorylcholine (Kim et al,
1991; Liu et al, 1998; Levade and Jaffre´zou, 1999). We had
previously shown that UVA radiation-induced ceramide con-
tent within the first two h after exposure (¼ early ceramide
response) was not caused by this mechanism, because UVA
radiation-induced ceramide content was not associated with
an increased activity of neutral or acid sphingomyelinase in
irradiated keratinocytes and because it was also observed in
a protein-free liposomal system (Grether-Beck et al, 2000).
This conclusion is corroborated by the present finding that
neither chloroquine, a well-known inhibitor of acid sphingo-
myelinase (Bonizzi et al, 1997), nor dichloroisocoumarine
(DCIC), a specific inhibitor of neutral sphingomyelinase
(Mansat et al, 1997), decreased UVA radiation-induced cer-
amide content 30 min post-exposure, although both inhib-
itors at identical concentrations significantly prevented
ceramide content by interleukin-1b, which is mediated
through sphingomyelinase activation (Bonizzi et al, 1997;
Grether-Beck et al, 2000) (Fig 2A,B). Similarly, both inhibitors
did not affect UVA radiation-induced ceramide content 16 h
after irradiation, indicating that neither the early nor the late
ceramide response involves sphingomyelinase activation
(Fig 2A,B). Identical results were obtained when scyphosta-
tin (Brann et al, 2002; Czarny et al, 2003; Numakawa et al,
2003) (Fig 2C) or spiroepoxide (Arenz and Giannis, 2001;
Ramer et al, 2003), two inhibitors of neutral sphingomyeli-
nase, were used (data not shown).
As ceramides can also be generated by degradation of
glycosphingolipids, we next asked whether the increase of
ceramide in irradiated cells is because of this mechanism.
For this purpose, keratinocytes were preincubated with
D,L-threo-PDMP (D-threo-(1R,2R)-1-phenyl-2-decanoylamino-
3-morpholinopropan-1-ol), which is an inhibitor of gluco-
sylceramide biosynthesis, i.e. the common precursor of all
glycosphingolipids formed in vertebrates (Kolter et al, 2002;
Sandhoff and Kolter, 2003). As is shown in Fig 2D, prein-
cubation with D,L-threo-PDMP did not affect UVA radiation-
induced ceramide content at all time points. In these
experiments, the glucosylceramide synthase inhibitor D,L-
threo-PDMP was active because it greatly reduced the for-
mation of the ganglioside GM3 (NeuAca2 ! 3Galb1 !
Figure 1
Ultraviolet A (UVA) irradiation results in biphasic (A) upregulation of
intercellular adhesion molecule-1 (ICAM-1) mRNA and (B) release
of ceramides in human normal keratinocyte. Keratinocytes were ir-
radiated with 30 J per cm2 UVA and harvested at the indicated time
points. (A) ICAM-1 mRNA expression was detected by real-time RT-
PCR based on b-actin as the housekeeping gene. (B) Ceramide release
was assessed in samples based on 500 mg protein using a Folch ex-
traction by high-performance thin layer chromatography on a CAMAG
AMD2 device. Data from irradiated cells (colored symbols) are given
in comparison with untreated controls (white symbols) that were set
equal to one. Data represent the mean  SD of three independent
experiments.
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4Glcb1-Cer) (Fig 2E), which is the predominant ganglioside
of the epidermis (Paller et al, 1992).
The third main pathway for ceramide production is de
novo synthesis (Bose et al, 1995; Perry et al, 2000). This
pathway is initiated by condensation of serine and palmi-
toyl-CoA, which is catalyzed by serine palmitoyltransferase,
to form 3-ketodihydrosphingosine. After reduction to di-
hydrosphingosine and subsequent conversion to di-
hydroceramide by ceramide synthase, ceramide is formed
by oxidation of dihydroceramide to introduce the trans-4,5
double bond. We had previously observed that UVA radi-
ation did not increase the activity of ceramide synthase
30 min after UVA irradiation and that addition of fumonisin
B1, a natural inhibitor of ceramide synthase (Merrill et al,
1993), did not prevent the early ceramide response
(Grether-Beck et al, 2000). This is in line with the present
observation that the early ceramide response was not af-
fected by treatment of keratinocytes with L-cycloserine (Fig
3A), which inhibits serine palmitoyltransferase (Sundaram
and Lev, 1984a, b). Also, inhibition of serine palmitoyltransf-
erase by the specific inhibitor myriocin (Miyake et al, 1995)
did not affect UVA radiation-induced ceramide content at
this early time point (Fig 3B). In marked contrast, 16 h after
UVA irradiation, both inhibitors prevented UVA radiation-in-
duced ceramide content (Fig 3A,B).
At the 16 h time point, UVA radiation was found to 2.5-
fold upregulate the activity of serine palmitoyltransferase,
whereas no such increase could be detected 1 h after UVA
irradiation (Fig 3C). This late increase in enzyme activity was
associated with an upregulation of the mRNA expression of
the 2 subunits encoding this enzyme (Fig 3D). The SPTLC1
subunit was induced 14-fold 16 h post-UVA, and the
SPTLC2 subunit showed a 7-fold induction after 24 h. An-
other possibility to consider is that the second ceramide
Figure 2
Ultraviolet A (UVA)-induced ceramide content is not because of
hydrolysis of sphingomyelin by sphingomyelinases or because of
degradation of glycosphingolipids. Ceramide release was assessed
in human normal keratinocyte 0.5 and 16 h after UVA (30 J per cm2)
treatment (light gray bar) with or without preincubation using inhibitors
for (A) acid sphingomyelinase such as chloroquine (100 mM) for 1 h
(horizontally hatched), for neutral sphingomyelinase such as (B)
3,4-dichloroisocoumarine (20 mM) for 0.5 h (dichloroisocoumarine,
horizontally crosshatched) or such as (C) scyphostatin (1 mM) for 1 h or
inhibitors for (D) glucosylceramide synthase such as D,L-threo-PDMP
(D-threo-(1R,2R)-1-phenyl-2-decanoylamino-3-morpholinopropan-1-ol;
10 mM diagonally cross-hatched) for 2 h in comparison with untreated
controls (white bars). Stimulation using 50 U per mL IL-1b for 0.5 h (dark
gray bar) was used as a positive control, as IL-b activates both types of
sphingomyelinases. (E) Quantification of GM3, the main ganglioside in
keratinocytes, was used as a positive control for the function of D,L-
threo-PDMP. Data represent the mean  SD of three independent ex-
periments.
Figure3
The second ultraviolet A (UVA)-induced ceramide release is be-
cause of de novo ceramide synthesis. Human normal keratinocytes
were preincubated with inhibitors of ceramide de novo synthesis, i.e.
(A) L-cycloserine (2 mM, rising left hatched) or (B) Myriocin (5 mM, di-
agonally crosshatched) for 0.5 h or left untreated prior to UVA irradi-
ation (30 J per cm2). Cells were harvested 0.5 and 16 h after UVA
treatment (light gray bar). Ceramide release was assessed as described
in the legend of Fig 1. Data are given in comparison with untreated
controls (white bars) that were set equal to one. Data represent the
mean  SD of three independent experiments. (C) Serine palmitoylt-
ransferase enzyme activity was detected in microsomal extracts based
on 50 mg protein from either untreated controls (white bar), UVA-treated
cells (light gray bars), and/or Myriocin (5 mM, 0.5 h) pretreated cells
(diagonally crosshatched). (D) UVA-induced mRNA expression of serine
palmitoyltransferase subunits SPTLC1 (light gray triangle down) or
SPTLC2 (black triangle down) was measured using real-time RT-PCR
based on b-actin as a housekeeping gene.
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peak might be produced because UVA radiation disrupts
the utilization of ceramide for sphingomyelin or glycosylcer-
amide synthesis. This is, however, very unlikely, because we
have observed that at these later time points sphingomyelin
and glycosphingolipid formation did not decrease in UVA-
irradiated cells (data not shown).
Role of the late ceramide response in UVA radiation-
induced gene expression The observation that the late,
but not the early, ceramide response could be prevented by
addition of myriocin to UVA-irradiated keratinocytes allowed
us to assess the functional relevance of the second ceramide
peak for UVA radiation-induced gene expression. As is
shown in Fig 4A,B, addition of myriocin at a concentration
that inhibited UVA radiation-induced serine palmitoyltransf-
erase activation (Fig 3C) and ceramide content (Fig 3B) in-
hibited UVA radiation-induced upregulation of ICAM-1
mRNA after 24 h and protein expression 16 and 24 h after
exposure. In contrast, 3 h after UVA irradiation, increased
ICAM-1 mRNA expression was not inhibited. Moreover, my-
riocin—at the indicated concentrations—inhibited UVA-in-
duced activation of transcription factor AP-2 as detected by
gel electrophoresis mobility shift assays in nuclear extracts
from keratinocytes 16 and 24 h after irradiation (Fig 4C).
Effects of ceramide on ceramide synthesis and serine
palmitoyltransferase activation In order to assess wheth-
er in UVA-irradiated keratinocytes the first and the second
ceramide response were connected to each other, keratin-
ocytes were left unirradiated and instead, cell-permeable
C6 ceramides were added as a surrogate for the first, UVA
radiation-induced ceramide peak. Subsequently, cells were
analyzed for ceramide content, serine palmitoyltransferase
mRNA expression, and activity. Addition of cell-permeable
ceramide, but not vehicle control, increased ceramide con-
tent in a time-dependent manner with an approximately
4-fold maximum after 8 h (Fig 5A). This response was long
lasting, because ceramide levels were still increased 3-fold
compared with background levels 48 h after stimulation.
Ceramide-induced ceramide content was associated with a
concomitant increase in mRNA expression of the SPTLC1
(2-fold) and the SPTLC2 (4-fold) subunit of serine palm-
itoyltransferase between 4 and 48 h with a maximum 24 h
after stimulation (Fig 5B). In addition, a 2.5-fold increase in
serine palmitoyltransferase activity 16 h after addition of
cell-permeable ceramide was found (Fig 5C). We therefore
next assessed the effect of myriocin on ceramide-induced
ceramide content. As is shown in Fig 5D, addition of my-
riocin completely abrogated ceramide-induced ceramide
content 16 h after ceramide stimulation. In aggregate, these
observations indicate that stimulation of keratinocytes with
exogenous ceramides induced de novo ceramide synthesis
in human keratinocytes through induction and activation of
serine palmitoyltransferase. In this regard, addition of ex-
ogenous ceramide induced a ceramide response, which
closely resembled the late ceramide response observed in
UVA-irradiated keratinocytes. We therefore next assessed
whether in UVA-irradiated keratinocytes the early ceramide
peak was a prerequisite for the formation of the later cer-
amide response.
Effects of vitamin E, ectoin, and cholesterol on UVA
radiation- and ceramide-induced ceramide content Be-
cause of the non-enzymatic nature of the early (Grether-
Beck et al, 2000, Figs 2 and 3) and the enzymatic nature of
the late ceramide response (Fig 3), we used a strategy that
allowed us to inhibit the early ceramide peak, but did not
prevent ceramide de novo synthesis. In this regard, we had
previously shown that the early UVA radiation-induced cer-
amide response was initiated through the generation of
singlet oxygen, and that it could be effectively prevented by
means of singlet oxygen quenchers including vitamin E
(Grether-Beck et al, 2000). In addition, in independent stud-
ies we have recently observed that preincubation of kera-
tinocytes with the osmolyte ectoin (Bu¨nger et al, 2001) or the
lipid cholesterin prevented UVA radiation-induced gene ex-
pression through inhibition of the early ceramide response
in UVA-irradiated keratinocytes. Accordingly, in UVA-irradi-
ated keratinocytes, pretreatment of cells with vitamin E,
Figure 4
Role of the second ceramide response in ultraviolet A (UVA)
radiation-induced gene expression. UVA-induced intercellular adhe-
sion molecule-1 (ICAM-1) (A) mRNA expression (gray bars) detected by
real-time RT-PCR and (B) protein expression (gray bars) detected by
flow cytometry as mean fluorescence intensity (MFI) were analyzed in
the presence (diagonally crosshatched bars) or absence of myriocin
(5 mM, 0.5 h preincubation) at the time points indicated. Data are given
in comparison with untreated controls (white bars) that were set equal
to one. Data represent the mean  SD of three independent exper-
iments. (C) Activation of transcription factor activator protein-2 (AP-2) in
nuclear extracts from Human normal keratinocytes, which had been
treated as indicated, was detected using gel electrophoresis mobility
shift assay. The result shown is representative of three essentially
identical experiments.
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ectoin, and cholesterol prevented the early, non-enzymatic
response (Table I). In all three cases, abrogation of the early
ceramide response was associated with the complete in-
hibition of the late ceramide response. This was not be-
cause of inhibition of ceramide de novo synthesis, because
vitamin E, ectoin, and cholesterol did not inhibit ceramide
synthesis in human keratinocytes induced after stimulation
of cells with cell-permeable C2 ceramide (data are only
shown for C2-, but were identical for C6-ceramide stimu-
lation) (Table I).
Discussion
In this study, we demonstrate that UVA radiation causes a
biphasic ceramide response in human keratinocytes with an
early maximum between 0.5 and 2 h and a late response
that can be detected 16 h after irradiation and that lasts up
to 48 h. In previous studies, the early ceramide response
was shown to be mediated by a non-enzymatic mechanism,
because UVA radiation-induced ceramide content was not
associated with an increased activity of neutral or acid
sphingomyelinase in irradiated keratinocytes and because
it was also observed in a protein-free liposomal system
(Grether-Beck et al, 2000). This is consistent with the
present observation that neither inhibitors of neutral and
acid sphingomyelinase (Fig 2), nor inhibitors of serine palm-
itoyltransferase (Fig 3A,B) affected UVA radiation-induced
ceramide content at these early time points. In the same
experiments, however, inhibition of serine palmitoyltransf-
erase activity by means of L-cycloserine or myriocin signif-
icantly decreased the late ceramide response (Fig 3A,B).
Also, at these later time points, UVA radiation-induced
Table I. Effects of vitamin E, ectoin, and cholesterol on









Vitamin E 1 1.0
Ectoin 1 0.9
Cholesterol 1 1.2





Vitamin E 16 1.0
Ectoin 16 0.9
Cholesterol 16 1.3
Vitamin E/UVA 16 1.3
Ectoin/UVA 16 0.7
Cholesterol/UVA 16 1.4
C2 ceramide 16 2.0
Vitamin E/C2 ceramide 16 2.3
Ectoin/C2 ceramide 16 2.6
Cholesterol/C2 ceramide 16 2.4
Keratinocytes were either preincubated for 1 h with vitamin E (25 mM),
ectoin (1 mM), or cholesterol (30 mM) or left untreated prior to stimulation
with UVA (30 J per cm2) or with C2 ceramide (10 mM). Cells were har-
vested after 1 or 16 h. The ceramide content was analyzed as described
in Materials and methods. The ceramide content is given as fold increase
compared with untreated time matched controls. Results are from one of
four essentially identical experiments.
Figure 5
Effects of ceramide on ceramide synthesis and serine palmitoylt-
ransferase activation. Addition of cell-permeable C6 ceramide
(10 mM) resulted in a time-dependent increase in (A) ceramide content
(gray square) assessed as described in the legend to Fig 1. Data
are given in comparison with untreated controls (white square) which
were set equal to one. Data represent the mean  SD of three
independent experiments. C6-ceramide-induced (B) upregulation of
serine palmitoyltransferase mRNA subunits SPTLC1 (light gray triangle
down) and SPTLC2 (black triangle up) was detected by real-time
RT-PCR based on b-actin as the housekeeping gene. Addition of C6
ceramide resulted in (C) induction of serine palmitoyltransferase
enzyme activity (gray bars) detected in microsomal extracts and in an
increased (D) ceramide content (gray bars) at the indicated time points.
This effect was abrogated by myriocin (5 mM, 0.5 h preincubation,
diagonally crosshatched).
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ceramide content was associated with an increase in serine
palmitoyltransferase activity (Fig 3C). In addition, the late
phase of ceramide content was not because of UVA-in-
duced degradation of glycosphingolipids (Fig 2D,E).
Taken together, these data demonstrate that UVA radi-
ation-induced ceramide content is initiated by a non-
enzymatic mechanism, which is followed by ceramide de
novo synthesis as a result of an increased activation of se-
rine palmitoyltransferase. Thus, the ceramide response in-
duced by UVA radiation involves both non-enzymatic and
enzymatic mechanisms.
UVA radiation-induced ceramide content and ICAM-1
gene expression show essentially identical biphasic kinetics
(Fig 1). Also, inhibition of the late ceramide response abol-
ished the late, but not the early, phase of increased gene
transcription (Fig 3), whereas inhibition of the first ceramide
peak prevented the first increase in gene expression
(Grether-Beck et al, 2000, Table I). We therefore propose
that the capacity of UVA radiation to elicit a biphasic cer-
amide response in human keratinocytes is responsible for
the biphasic nature of UVA radiation-induced gene expres-
sion and transcription factor activation. The in vivo relevance
of UVA-induced ceramide synthesis is not known. In this re-
gard, it is worth mentioning that previous studies by
Lehmann et al (1991) and Wefers et al (1991) indicate, that
UVB, but also UVA radiation improve skin barrier function. In
addition, animal studies have revealed that UVB radiation is
capable of inducing SPT expression and ceramide synthesis.
The kinetics of the UVB effects, which are monophasic
(Holleran et al, 1997), differ from the biphasic pattern ob-
served in our study for UVA. This further emphasizes
the specificity of the biphasic activation pattern for UVA
radiation.
Activation of serine palmitoyltransferase and a concom-
itant increase in ceramide content was not only observed in
UVA-irradiated keratinocytes but also in cells that had been
left unirradiated but were stimulated with cell-permeable C2
or C6 ceramide. Stimulation of keratinocytes with ex-
ogenous ceramide can thus be regarded as a substitute
for the early ceramide response in UVA-irradiated cells, in-
dicating that the early and the late ceramide response are
not independent from each other, but are possibly con-
nected in an autocrine manner. In keeping with this hypoth-
esis, we have observed that abrogation of the first ceramide
peak through strategies that did not interfere with ceramide
de novo synthesis always prevented the second ceramide
response as well. Based on these observations, we would
like to propose a model (Fig 6) in which ceramide that is
formed upon UVA irradiation through a non-enzymatic
mechanism induces–in an autocrine manner—the expres-
sion and activation of serine palmitoyltransferase and there-
by a second increase in ceramide production. This model
would also help to explain the long-lasting nature of the
late ceramide response, because newly synthesized cer-
amide could lead to a perpetuation of serine palmitoylt-
ransferase activity and ceramide synthesis. Accordingly,
ceramide content (Fig 1B) and serine palmitoyltransferase
expression (Fig 3D) were still increased above background
levels 48 h after UVA irradiation. Lipid-mediated autocrine/
paracrine signaling has previously been reported for
sphingosine-1-phosphate (Maceyka et al, 2002). In these
studies, platelet-derived growth factor-induced cell motility
was found to be mediated via stimulation of sphingosine
kinase and the subsequent production of intracellular
sphingosine-1-phosphate that can act in an autocrine or
paracrine manner and thereby may activate a family of cell
surface sphingosine-1-phosphate specific G-protein-cou-
pled receptors, which subsequently leads to an activation of
prosurvival pathways (Liu et al, 2000; Hobson et al, 2001).
To the best of our knowledge, this is a report that suggests
that ceramide may be involved in an autocrine signaling
loop as well.
Generation of endogenous ceramide in response to ex-
ogenously added, cell-permeable ceramide has previously
been observed in the human lung carcinoma cell line A549
(Ogretmen et al, 2002). In this study, ceramide-induced
ceramide content was found to be because of recycling of
the C6-ceramide sphingosine backbone of via deacylation/
reacylation, and not to ceramide de novo synthesis. Con-
trary to these findings, we demonstrate in this study that, in
non-transformed, primary human epidermal keratinocytes
exogenously added ceramide can induce endogenous cer-
amide content through de novo synthesis via activation of
serine palmitoyltransferase.
Serine palmitoyltransferase is a heterodimer consisting
of the 53 kDa SPTLC1 subunit and of the 63 kDa SPTLC2
subunit, both of which are bound to the endosplasmatic
reticulum as integral membrane proteins (Hanada, 2003). In
mammalian cells, SPTLC2 alone was found to be sufficient
to achieve serine palmitoyltransferase activity, and it has
therefore been proposed that SPTLC2 encodes for the cat-
alytic activity of this enzyme (Weiss and Stoffel, 1997). Ac-
cordingly, in this study, UVA radiation/ceramide stimulation
increased mRNA expression of the SPTLC2 subunit 6- and
4-fold, respectively. Upregulation of the SPTLC1 subunit
was found to be stronger after UVA radiation (up to 14-fold)
than after ceramide stimulation (maximal 2-fold). In addition,
Figure6
Model of ultraviolet A (UVA)-induced signaling. UVA causes singlet-
oxygen-mediated increase in ceramide content (via a non-enzymatic
hydrolysis), leading to activation of activator protein-2 (AP-2) resulting
in an induced gene transcription of intercellular adhesion molecule-1
(ICAM-1) and serine palmitoyltransferase (SPT1/SPT2). Upregulation of
SPT1/SPT2 leads to an increased SPT1/SPT2 enzyme activity within
the endoplasmatic reticulum resulting in a second increase in ceramide
content, which in turn mediates AP-2 activation and a second ICAM-1
mRNA transcription.
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SPTLC2 mRNA expression was found to be more sustained
in UVA-irradiated compared with ceramide-stimulated
keratinocytes. These observations are in line with the con-
cept that the SPTLC1 subunit may have stabilizing functions
(Weiss and Stoffel, 1997). UVB-induced upregulation of
SPTLC2 mRNA and protein as well as enzyme activity has
been observed 48 and 72 h post-application of 230 J per m2
(Farrell et al, 1998). Moreover, studies using an apoptogenic
dose of UVB (600 J per m2) resulted in a 3.2-fold increase
in ceramide content 8 h post-treatment because of an in-
creased ceramide synthase activity (Uchida et al, 2003).
Although this increase in ceramide content is comparable
with the second ceramide peak detected upon UVA expo-
sure, it is important to note that in this study, UVA-induced
ceramide generation occurred without a reduction in cell
viability or an increase in cell death (Grether-Beck et al,
1996, 2000; Warskulat et al, 2004). Although the action
spectrum for the biphasic ceramide generation has not
been determined, it is reasonable to speculate that the ob-
served ceramide formation is because of UVA1 (340–400
nm) radiation, since the light source in the study used emits
UVA in the range of 340–400 nm with a peak at 360 nm.
Serine palmitoyltransferase, which catalyzes the initial
and committed step in sphingolipid synthesis, is thought to
be a housekeeping enzyme that is supposedly regulated,
but only relatively few findings demonstrate its regulation
and its regulatory mechanisms (Hanada, 2003). Until the
regulatory genetic elements within the promoters or introns
of SPTLC1 and SPTLC2, respectively, are available an in-
duction by activation of transcription factors such as AP-2
remains speculative. At present, it also cannot be excluded
that alterations in mRNA half-life contribute to increased
SPTLC1 and SPTLC2 mRNA steady-state levels (Raghavan
et al, 2002).
In conclusion, we demonstrate here that the previously
observed biphasic nature of the UVA response in human
keratinocytes (Grether-Beck et al, 1996; Morita et al, 1997;
Gille et al, 2000) results from the sequential triggering of
non-enzymatic and enzymatic pathways that lead to the
biphasic formation of the second messenger ceramide. We
also show that ceramide can act in an autocrine manner to
stimulate the de novo synthesis of ceramide.
Materials and Methods
Materials 3,4-DCIC, chloroquine, L-cycloserine, myriocin, and vi-
tamin E succinate were purchased from Sigma-Aldrich (Munich,
Germany). Interleukine-1a was obtained from R&D Systems
(Wiesbaden-Norderstadt, Germany). DL-threo-PDMP (DL-threo-1-
phenyl-2-decanoylamino-3-morpholino-1-propanol HCL) was ob-
tained from Matreya (Pleasant Gap, Pennsylvania). Scyphostatin
was a kind gift from Sancyo (Tokyo, Japan). N-[2-hydroxy-1-(8-
oxo-1-oxa-spiro[2.5]octa-4,6-diene-5-ylcarbamoyl)-ethyl] decan-
amide was kindly provided by Prof. A. Giannis (Institute for Or-
ganic Chemistry, University of Leipzig, Germany).
Cell-permeable C6 ceramide (D-erythro-sphingosine, N-hex-
anoyl), ceramide standards, and ganglioside GM3 (Neu5Aca2,
3Galb1,4Glcb1,1Cer, NH4) for lipid quantification and cholesterol
were from Merck Biosciences (Bad Soden, Germany). Ectoin was
obtained from Bitop (Witten, Germany).
Cell culture Long-term cultured, human normal keratinocytes
(HNK) prepared from neonatal foreskin were cultured under serum-
free conditions for up to five passages (Grether-Beck et al, 1996,
2000, 2003).
UV radiation For UVA radiation, medium was replaced by
phosphate-buffered saline, lids were removed, and cells were ex-
posed to a dose of 30 J per cm2 UVA1 using a UVASUN 24.000
system (Sellas GmbH, Dr Sellmeier Gevelsberg, Germany).
The UVA1 output was determined with a UVAMETER type II
(Waldmann, Villingen-Schwenningen, Germany) and was found to
be approximately 150 mW per cm2 UVA1 at a tube to target dis-
tance of 30 cm (Grether-Beck et al, 1996, 2000).
Lipid extraction Cells were harvested at the indicated time points
by scrapping the cells off the plate on ice. Pellets were washed and
sonicated. Quantification of lipids was carried out using 500 mg
protein (Bradford, 1976) for Folch extraction (Folch et al, 1957).
Analysis of ceramides included a mild alkaline hydrolysis. The
lower phase of Folch extraction was evaporated under nitrogen.
The lipids were dissolved in chloroform/methanol (2:1, v/v). As
more complex glycolipids and the gangliosides are soluble in wa-
ter, these substances are lost during washing included in the Folch
procedure. Therefore, the aqueous phase of the Folch extraction
was collected, desalted by column chromatography using Oasis
HLB extraction cartridges (Waters GmbH, Eschborn, Germany)
according to the instructions of the manufacturer, and eluted with
chloroform methanol (2:1, v/v).
High-performance thin layer chromatography (HPTLC) Sam-
ples and standards were separated on silica gel HPTLC plates
(20  10 cm) Merck 60 F 254 s (Merck KGaA, Darmstadt, Germa-
ny), prewashed for 60 min in 2-propanol, and dried for 30 min at
1201C.
Samples and standards were applied to the TLC plates using a
CAMAG Linomat IV (CAMAG, Berlin, Germany) in bands of 0.8 cm
by a spray-on technique (10 mL per sample) in which nitrogen car-
rier gas atomizes the sample from a syringe onto the plate, which is
moving back and forth under the atomizer.
For determination of ceramides, samples were separated using
an Automated Multiple Development (AMD) procedure on an
AMD2 device (CAMAG). This procedure consisted of seven re-
peated developments of the chromatogram using a stepwise el-
ution gradient with methanol, dichloromethane, and n-hexane
(methanol/dichloromethane/n-hexane: 100/0/0; 10/90/0; 9/91/0;
8/92/0; 3/97/0; 2/98/0; 0/0/100) based on the CAMAG application
protocol A 52.3 for separation of phospholipids (Jork et al, 1989) on
a CAMAG AMD2 device as described earlier (Grether-Beck et al,
2000). For determination of glycosphingolipids, e.g. GM3 a 19-
step gradient based on methanol, dichloromethane, and n-hexane
(methanol/dichloromethane/n-hexane: 100/0/0; 80/20/0; 78/22/0;
74/24/0; 69/31/0; 62/38/0; 54/46/0; 47/53/0; 40/60/0; 33/67/0; 25/
75/0; 18/82/0; 11/89/0; 7/93/0; 4/96/0; 2/98/0; 1/99/0; 0/100/0;
0/0/100) was used.
Visualization of separated bands was carried out by post-chro-
matic derivatization after dipping in a manganese chloride solu-
tion according to Grether-Beck et al (2000). Therefore, 0.4 g
MnCl2 4H2O was solved in 60 mL H2O under heating, 60 mL
methanol, and 4 mL concentrated H2SO4 were added, and the
solution was cooled down to room temperature. Derivatization was
carried out in an automated dipping device (CAMAG) at a vertical
speed of 50 mm per s and an immersion time of 1 s. After heating,
the plate for 10 min at 1201C in a temperature-controlled oven, the
plate was dried and scanned using a CAMAG TLC Scanner II and
CATS software. Quantification was carried out by absorption at
550 nm with a plot of peak area versus weight spotted for a series
of standards using a second-order polynomial calibration.
Serine palmitoyltransferase activity Enzyme activity was as-
sessed in microsomal preparations of keratinocytes prepared as
previously described in detail (Liu et al, 1994; Grether-Beck et al,
2000). In brief, cells grown on 10 cm dishes were pelleted, washed
once with cold PBS, and resuspended in 300 mL of homogenization
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buffer (25 mM HEPES pH 7.4) followed by the addition of protein-
ase inhibitors (Complete, Boehringer Mannheim, Germany). Cells
were disrupted using a tissue homogenizer (POTTER, B. Braun
Biotech Int., Goettingen, Germany). Lysates were centrifuged at
800  g for 5 min. The post-nuclear supernatant was centrifuged
at 250,000  g for 30 min. The microsomal membrane pellet was
resuspended in 1.0 mL of homogenization buffer. Membranes were
freshly prepared. Serine palmitoyltransferase activity was deter-
mined based on the procedure described elsewhere (Williams et al,
1984; Dickson et al, 2000) in aliquots of 50 mg microsomal protein
(determined according to Bradford, 1976). The determination of
SPT activity was based on the conversion of the water-soluble
substrate L-[3-14C] serine to the chloroform-soluble product 3-
ketosphinganine. In brief, the final reaction volume of 0.1 mL con-
tained 100 mM HEPES (pH 8.3), 5 mM DTT, 2.5 mM EDTA (pH 7),
50 mM pyridoxal phosphate, 200 mM palmitoyl-CoA, 1 mM serine L-
[3-14C] serine (specific activity 2.11 GBq per mmol), and 50 mg
microsomal protein. The reaction was initiated by the addition of
palmitoyl-CoA to avoid depletion of this substrate by fatty acyl-
CoA hydrolases and incubated for 10 min at 371C on a shaker. The
reaction was terminated by addition of 1.5 mL chloroform–meth-
anol (1:2, v/v), and the lipophilic product 3-ketospinganine was
isolated by phase separation and quantified by a standard scin-
tillation procedure (Beckman, Beckman Coulter GmbH, Krefeld,
Germany) using Quicksafe N as scintillation fluid (Zinsser Analytik
GmbH, Frankfurt, Germany). Enzyme activity was expressed as
picomoles of 3-ketosphinganine formed per minute per milligram
of protein. Background correction to exclude impurities of serine
was performed the same way, except that palmitoyl-CoA was
omitted. Results are given as fold induction in comparison with
unstimulated controls.
Real-time RT-PCR Total RNA was isolated using RNeasy Total
RNA Kits (Qiagen, Hilden, Germany). Two-step real-time RT-PCR
was performed to detect gene expression in human keratinocytes.
SuperScript III First-Strand Synthesis System for RT-PCR (Invitro-
gen, Karlsruhe, Germany) was used for the reverse transcription
step with random hexamers. For each gene, a specific PCR primer
pair was designed by Primer Express 2.0 software (Applied Bio-
systems, Darmstadt, Germany) based on the cDNA sequence
published as indicated: b-actin 50-CCTGGCACCCAGCACAAT-30/
50-GCCGATCCACACGGAGTACT-30, (Vandekerckhove and Weber,
1978; Ponte et al, 1984); ICAM-1 50-CCTGGCACCCAGCACAAT-30/
50-GCCGATCCACACGGAGTACT-30 (Staunton et al, 1988); SPTLC1
50- GCGCGCTACTTGGAGAAAGA-30 /50-TGTTCCACCGTGACCAC-
AAC-30, SPTLC2 50-AGCCGCCAAAGTCCTTGAG-30/50-CTTGTC-
CAGGTTTCCAATTTCC-30 (Weiss and Stoffel, 1997).
The PCR reactions were carried out on an Opticon 1 (MJ Re-
search, Waltham, Massachusetts) using SYBR Green PCR Master
Mix (Applied Biosystems). Each RT-PCR experiment was per-
formed twice.
Flow cytometry ICAM-1 cell surface expression was assessed by
a one-step staining procedure and subsequent flow cytometry
(FACS analysis). Cells were detached from the plates by a brief
trypsin treatment. After washing, cells were stained with an R-
phycoerythrin-coupled murine anti-human ICAM-1 monoclonal an-
tibody CD54 (Leu-54) (Becton Dickinson PharMingen, Heidelberg,
Germany). Control stainings were performed with an isotype-
matched control monoclonal antibody (mouse IgG1). Stained cells
were analyzed in a FACScan II flow cytometer (BD PharMingen,
Heidelberg, Germany). Data are given as mean fluorescence inten-
sity (MFI) based on unstimulated controls that were set equal to one.
Gel electrophoresis mobility shift assay Nuclear extracts were
prepared according to the Dignam protocol as described (Dignam
et al, 1983). The AP-2 consensus oligonucleotide (top strand,
50-ACCCTCTCGGCCCGGGCACCCT-30) was deduced from the
ICAM-1 promoter (Stade et al, 1990). Specificity controls were
performed as before (Grether-Beck et al, 1996).
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